HaleonHLN -0.32%70 Forward Dividend Yield % is 2.09% as of Jun. 28, 2026. GuruFocus rates HLN with a GF Score™ of 70/100 and a GF Value™ of $9.63 (Fairly Valued). The stock has 3 warning signs investors should review. Among 505 Drug Manufacturers companies, Haleon ranks worse than 51.88% on this metric.
As of today (2026-06-28), the Forward Annual Dividend Yield of Haleon is 2.09%.
As of today (2026-06-28), the Trailing Annual Dividend Yield of Haleon is 2.09%.
HLN's Forward Dividend Yield % is ranked worse than 51.88% of 505
companies
in the Drug Manufacturers industry
Industry Median: 2.14
vs HLN: 2.09
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
HLN vs ZTS, UTHR, VTRS: Forward Dividend Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Haleon's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Haleon Forward Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Haleon's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Haleon's Forward Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Haleon Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
USD 0.133292
2026-04-10
2026-04-10
2026-05-14
Cash Dividend
semi-annually
USD:USD 1.000000
USD 0.059783
2025-08-15
2025-08-15
2025-09-18
Cash Dividend
semi-annually
USD:USD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Haleon's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
0.266584
/
9.24
=
2.89 %
Current Share Price is $9.24. Haleon's Dividends per Share for the forward twelve months is calculated as $0.133292 * 2 = $0.266584.
Haleon's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
0.193075
/
9.24
=
2.09 %
Current Share Price is $9.24. Haleon's Dividends per Share for the trailing twelve months (TTM) ended in Today is $0.193075.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 2.09% mean?
Haleon (HLN) has a Forward Dividend Yield % of 2.09% as of Jun. 28, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Haleon and its competitors. According to the industry distribution chart, Haleon ranks #262 out of 505 companies in the Drug Manufacturers industry, placing it in the top 51.9%.
Is Haleon's Forward Dividend Yield % too high?
Haleon's current Forward Dividend Yield % is 2.09%. The Drug Manufacturers industry median Forward Dividend Yield % is 2.14. Haleon's value of 2.09% is 2.3% below this industry median. Based on the distribution chart, Haleon ranks #262 out of 505 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Haleon has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Haleon's Forward Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Haleon ranks #262 out of 505 companies for Forward Dividend Yield %. This places Haleon in the lower half of its industry. The industry median Forward Dividend Yield % is 2.14. Haleon's value of 2.09% is 2.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.14, based on 505 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Haleon's current Forward Dividend Yield % of 2.09% is 2.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Haleon and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Haleon's current Forward Dividend Yield % is 2.09%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haleon stock overvalued right now?
Based on GuruFocus' analysis, Haleon (HLN) is currently considered Fairly Valued. The stock's GF Value™ is $9.63, compared to a current price of $9.24 — trading 4% below its estimated fair value. The current Forward Dividend Yield % is 2.09% and 2.3% below the Drug Manufacturers industry median of 2.14. Haleon's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Haleon (HLN), the current Forward Dividend Yield % is 2.09% as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Haleon (HLN) Overvalued in 2026?
Based on GuruFocus' analysis, Haleon stock appears to be undervalued.
The current stock price of $9.24 is trading 4% below its estimated GF Value™ of $9.63.
GuruFocus considers Haleon to be Fairly Valued.
Key valuation signals for HLN:
Forward Dividend Yield %: 2.09%
GF Value™: $9.63 vs. price of $9.24 (4% below fair value)
Industry Position: 2.3% below the Drug Manufacturers median (#262 of 505)
No single metric tells the full story. See the HLN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
70GF Score
Get the complete analysis for HLN
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HLN has been successfully added to your 